IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 3 holdings | $246.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$191.7M19,363,97577.9%
Pliant Therapeutics, Inc.(PLRX)COM729139105$38.6M2,132,86715.7%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$15.8M2,343,1546.4%